How surging wages and record tax rises threaten to reignite inflation
OTLK Stock | USD 2.24 0.18 8.74% |
About 55% of OUTLOOK THERAPEUTICS's institutional investors are presently thinking to get in. The analysis of the overall investor sentiment regarding OUTLOOK THERAPEUTICS INC suggests that some traders are interested. OUTLOOK THERAPEUTICS's investing sentiment shows overall attitude of investors towards OUTLOOK THERAPEUTICS INC.
OUTLOOK |
Christine Lagarde, the president of the European Central Bank, effectively declared victory over eurozone inflation on Monday saying The darkest days of winter look to be behind us.
Read at finance.yahoo.com
OUTLOOK THERAPEUTICS Fundamental Analysis
We analyze OUTLOOK THERAPEUTICS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OUTLOOK THERAPEUTICS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OUTLOOK THERAPEUTICS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
OUTLOOK THERAPEUTICS is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
OUTLOOK THERAPEUTICS INC Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with OUTLOOK THERAPEUTICS stock to make a market-neutral strategy. Peer analysis of OUTLOOK THERAPEUTICS could also be used in its relative valuation, which is a method of valuing OUTLOOK THERAPEUTICS by comparing valuation metrics with similar companies.
Peers
OUTLOOK THERAPEUTICS Related Equities
CKPT | Checkpoint Therapeutics | 10.94 | ||||
INZY | Inozyme Pharma | 7.72 | ||||
PLX | Protalix Biotherapeutics | 7.61 | ||||
KOD | Kodiak Sciences | 5.80 | ||||
FBIO | Fortress Biotech | 5.19 | ||||
MBIO | Mustang Bio | 4.76 | ||||
HRTX | Heron Therapeuti | 3.75 | ||||
EYPT | Eyepoint Pharmaceuticals | 2.86 | ||||
TERN | Terns Pharmaceuticals | 1.41 | ||||
SLS | Sellas Life | 0.93 | ||||
DAWN | Day One | 0.94 | ||||
FBIOP | Fortress Biotech | 1.31 | ||||
XFOR | X4 Pharmaceuticals | 1.33 | ||||
CDTX | Cidara Therapeutics | 2.49 | ||||
HOOK | Hookipa Pharma | 4.62 | ||||
RVPH | Reviva Pharmaceuticals | 5.47 | ||||
EYEN | Eyenovia | 8.33 |
Check out OUTLOOK THERAPEUTICS Hype Analysis, OUTLOOK THERAPEUTICS Correlation and OUTLOOK THERAPEUTICS Performance. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OUTLOOK THERAPEUTICS. If investors know OUTLOOK will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OUTLOOK THERAPEUTICS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of OUTLOOK THERAPEUTICS INC is measured differently than its book value, which is the value of OUTLOOK that is recorded on the company's balance sheet. Investors also form their own opinion of OUTLOOK THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is OUTLOOK THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OUTLOOK THERAPEUTICS's market value can be influenced by many factors that don't directly affect OUTLOOK THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OUTLOOK THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine if OUTLOOK THERAPEUTICS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OUTLOOK THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.